These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9635713

  • 1. Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors.
    Horn V, Slánský J, Janku I, Strouf O, Sourek K, Tovarys F.
    Int J Radiat Oncol Biol Phys; 1998 Jun 01; 41(3):631-8. PubMed ID: 9635713
    [Abstract] [Full Text] [Related]

  • 2. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
    Haritz D, Gabel D, Huiskamp R.
    Int J Radiat Oncol Biol Phys; 1994 Mar 30; 28(5):1175-81. PubMed ID: 8175403
    [Abstract] [Full Text] [Related]

  • 3. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.
    Neurosurgery; 2000 Sep 30; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [Abstract] [Full Text] [Related]

  • 4. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E, Zaboronok A, Kanygin V, Kasatova A, Kichigin A, Mukhamadiyarov R, Razumov I, Sycheva T, Mathis BJ, Maezono SEB, Matsumura A, Taskaev S.
    Int J Radiat Biol; 2020 Jul 30; 96(7):868-878. PubMed ID: 32339057
    [Abstract] [Full Text] [Related]

  • 5. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):663-72. PubMed ID: 9112465
    [Abstract] [Full Text] [Related]

  • 6. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy.
    Ceberg CP, Persson A, Brun A, Huiskamp R, Fyhr AS, Persson BR, Salford LG.
    J Neurosurg; 1995 Jul 01; 83(1):79-85. PubMed ID: 7782854
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T, Nagahiro S, Kitamura K, Nakagawa Y, Hatanaka H, Haritz D, Grochulla F, Haselsberger K, Gabel D.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):120-30. PubMed ID: 11516861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
    Suzuki M, Nagata K, Masunaga S, Kinashi Y, Sakurai Y, Maruhashi A, Ono K.
    Appl Radiat Isot; 2004 Nov 01; 61(5):933-7. PubMed ID: 15308171
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G, Kawabata S, Nonoguchi N, Hiramatsu R, Toho T, Tanaka H, Masunaga SI, Hattori Y, Kirihata M, Ono K, Kuroiwa T, Miyatake SI.
    Radiat Oncol; 2017 Jan 23; 12(1):26. PubMed ID: 28114947
    [Abstract] [Full Text] [Related]

  • 16. Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors.
    Kraft SL, Gavin PR, DeHaan CE, Leathers CW, Bauer WF, Miller DL, Dorn RV.
    Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11973-7. PubMed ID: 1465427
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T, Nakagawa Y, Kitamura K, Matsumoto K, Hatanaka H.
    J Neurooncol; 1997 May 15; 33(1-2):117-30. PubMed ID: 9151229
    [Abstract] [Full Text] [Related]

  • 18. Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.
    Garabalino MA, Heber EM, Monti Hughes A, González SJ, Molinari AJ, Pozzi EC, Nievas S, Itoiz ME, Aromando RF, Nigg DW, Bauer W, Trivillin VA, Schwint AE.
    Radiat Environ Biophys; 2013 Aug 15; 52(3):351-61. PubMed ID: 23591915
    [Abstract] [Full Text] [Related]

  • 19. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
    Suzuki M, Sakurai Y, Masunaga S, Kinashi Y, Nagata K, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):892-6. PubMed ID: 14967447
    [Abstract] [Full Text] [Related]

  • 20. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T, Nagahiro S, Otersen B, Gabel D, Nakaichi M, Nakagawa Y.
    J Neurooncol; 2002 Sep 01; 59(2):135-42. PubMed ID: 12241106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.